Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001762507-26-000002

SVP, CFO, CBO & Treasurer sold 34,951 shares at $1.39 ($48,582)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ostrowski Erik · SVP, CFO, CBO & Treasurer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Sale : show line 1 in the form 10b5-1 −34,951 $1.39 $48,582 672,635 D
Open-market sales · 34,951 sh · avg $1.39 · $48,582
Loading xslF345X05/primarydocument.xml…